BridgeMD
Compares treatment options for Endometriosis
Official title Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy
ClinicalTrials.gov ID: NCT07065214
What this study is testing
- What it's testing
- The study is a prospective, monocentric, randomized controlled, two-armed, pilot-study conducted at Department for Women's Health, Tuebingen, Germany. In this Post Market Study it will be determined whether and to what extent the two surgical procedures for ovarian endometrioma treatment (standard cystectomy versus APC) may affect the ovarian reserve by comparing changes in serum AMH levels after treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- Indication for surgical endometrioma treatment according to patient symptoms
- Signed informed consent
You likely can't join if
- Expected lack of patient compliance or inability of the patient to understand the purpose of the clinical trial
- Prior procedures at the ovaries
- Recurrent endometrioma (patients with recurrent endometriosis outside of the ovar, e.g. peritoneal endometriosis lesions can be included)
- Pregnant or breastfeeding patients
- Participation in any other clinical study that could affect the AMH level or pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Tübingen, Germany, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tübingen, Germany, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.